At-home Healthcare Expansion Will Capture Growing Demand

Published
24 Sep 24
Updated
20 Aug 25
AnalystConsensusTarget's Fair Value
US$3.05
43.6% undervalued intrinsic discount
20 Aug
US$1.72
Loading
1Y
-53.8%
7D
6.2%

Author's Valuation

US$3.1

43.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 30%

Shared on23 Apr 25
Fair value Increased 44%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 30%

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Increased 65%

AnalystConsensusTarget has decreased revenue growth from -20.5% to -6.4%, decreased profit margin from 1.5% to 1.2% and decreased future PE multiple from 169.7x to 99.4x.